24 articles in this topic
UC Riverside scientists developed a gel that delivers continuous oxygen to chronic wounds, healing fatal injuries in diabetic mice within weeks.
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for a safe, accessible treatment.
A newly defined health condition linking heart, kidney, and metabolic problems affects nearly all adults, but awareness remains critically low.
Experimental diabetes drug IC7Fc reduces cholesterol and artery plaque buildup, offering cardiovascular benefits even without weight loss.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
New research shows blood sugar can normalize without losing weight by shifting harmful belly fat to healthier locations under the skin.
Large study of 8,000 patients reveals stopping GLP-1 drugs doesn't guarantee weight regain as many restart treatment or adopt lifestyle changes.
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for 30% of people affected globally.
Brazilian researchers found the deadly combination of excess abdominal fat and low muscle mass can be detected with simple measurements.
Researchers discover how SLIT3 protein helps brown fat build blood vessels and nerves needed to burn calories instead of storing them as fat.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
